Primecap Management’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-54,000
| Closed | -$222K | – | 336 |
|
|
2024
Q3 | $222K | Hold |
54,000
| – | – | ﹤0.01% | 335 |
|
|
2024
Q2 | $194K | Hold |
54,000
| – | – | ﹤0.01% | 331 |
|
|
2024
Q1 | $178K | Hold |
54,000
| – | – | ﹤0.01% | 333 |
|
|
2023
Q4 | $125K | Sell |
54,000
-25,000
| -32% | -$57.8K | ﹤0.01% | 334 |
|
|
2023
Q3 | $102K | Sell |
79,000
-78,700
| -50% | -$102K | ﹤0.01% | 331 |
|
|
2023
Q2 | $208K | Sell |
157,700
-138,830
| -47% | -$183K | ﹤0.01% | 326 |
|
|
2023
Q1 | $210K | Sell |
296,530
-700
| -0.2% | -$495 | ﹤0.01% | 329 |
|
|
2022
Q4 | $223K | Sell |
297,230
-17,530
| -6% | -$13.1K | ﹤0.01% | 330 |
|
|
2022
Q3 | $271K | Sell |
314,760
-6,900
| -2% | -$5.94K | ﹤0.01% | 332 |
|
|
2022
Q2 | $360K | Sell |
321,660
-9,240
| -3% | -$10.3K | ﹤0.01% | 336 |
|
|
2022
Q1 | $371K | Sell |
330,900
-1,300
| -0.4% | -$1.46K | ﹤0.01% | 336 |
|
|
2021
Q4 | $532K | Sell |
332,200
-7,400
| -2% | -$11.9K | ﹤0.01% | 337 |
|
|
2021
Q3 | $822K | Sell |
339,600
-149,338
| -31% | -$361K | ﹤0.01% | 333 |
|
|
2021
Q2 | $1.55M | Sell |
488,938
-162
| -0% | -$514 | ﹤0.01% | 318 |
|
|
2021
Q1 | $1.65M | Hold |
489,100
| – | – | ﹤0.01% | 313 |
|
|
2020
Q4 | $1.75M | Hold |
489,100
| – | – | ﹤0.01% | 304 |
|
|
2020
Q3 | $1.28M | Hold |
489,100
| – | – | ﹤0.01% | 297 |
|
|
2020
Q2 | $1.5M | Sell |
489,100
-54,275
| -10% | -$166K | ﹤0.01% | 283 |
|
|
2020
Q1 | $560K | Sell |
543,375
-58,387
| -10% | -$60.2K | ﹤0.01% | 283 |
|
|
2019
Q4 | $1.97M | Sell |
601,762
-81,594
| -12% | -$268K | ﹤0.01% | 274 |
|
|
2019
Q3 | $1.98M | Sell |
683,356
-12,754
| -2% | -$37K | ﹤0.01% | 274 |
|
|
2019
Q2 | $1.67M | Buy |
+696,110
| New | +$1.67M | ﹤0.01% | 281 |
|